Add To Favorites
AstraZeneca CEO considers moving company listing to US, the Times reports
- 7/1/2025
(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times reported on Tuesday, citing multiple sources.
Soriot has privately expressed a preference to shift the FTSE 100 company's listing on multiple occasions and has also discussed relocating AstraZeneca's domicile, the report said.
The company declined to comment on the report.
The UK pharmaceutical giant already has American depositary receipts trading in the U.S.
Soriot could face opposition from some board members and the British government if he pursues the move, according to the report, adding that the government has not been informed.
London-listed shares in AstraZeneca were up 2.7% at 10,400 pence at 1504 GMT.
(Reporting by Aatrayee Chatterjee and Shanima A in Bengaluru, and Maggie Fick in London; Editing by Leroy Leo)